VentriJect

The company develops the Seismofit System, a medical device that estimates cardiorespiratory fitness (VO2 max) by recording chest wall vibrations through seismocardiography. The technology utilizes an AI algorithm to provide results in less than three minutes while the user is at rest, eliminating the need for strenuous physical exercise. The product is marketed to health professionals, sports medicine doctors, and corporate health programs as a tool for clinical vital sign assessment and longevity screening.